Sen-Jam Pharmaceutical has a total of 40 patents globally, out of which 10 have been granted. Of these 40 patents, more than 70% patents are active. The United States of America is where Sen-Jam Pharmaceutical has filed the maximum number of patents, followed by Europe (EPO) and Australia. Parallelly, The United States of America seems to be the main focused R&D center and also origin country of Sen-Jam Pharmaceutical.
Sen-Jam Pharmaceutical was founded in the year 2014. Sen-Jam Pharmaceutical is a medical company that uses the development pathway to create innovative pharmaceutical solutions for significant unmet needs.
Do read about some of the most popular patents of Sen-Jam Pharmaceutical which have been covered by us in this article and also you can find Sen-Jam Pharmaceutical patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Sen-Jam Pharmaceutical patent portfolio.
How many patents does Sen-Jam Pharmaceutical have?
Sen-Jam Pharmaceutical has a total of 40 patents globally. These patents belong to 9 unique patent families. Out of 40 patents, 28 patents are active.
How Many Patents did Sen-Jam Pharmaceutical File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | Sen-Jam Pharmaceutical Applications Filed | Sen-Jam Pharmaceutical Patents Granted |
2023 | 3 | 1 |
2022 | 2 | 5 |
2021 | 8 | 1 |
2020 | 2 | 2 |
2019 | 3 | 1 |
2018 | 15 | – |
2016 | 7 | – |
How many Sen-Jam Pharmaceutical patents are Alive/Dead?
Worldwide Patents
How Many Patents did Sen-Jam Pharmaceutical File in Different Countries?
Countries in which Sen-Jam Pharmaceutical Filed Patents
Country | Patent |
United States Of America | 13 |
Europe | 5 |
Australia | 3 |
Canada | 2 |
Mexico | 1 |
Poland | 1 |
New Zealand | 1 |
Brazil | 1 |
Austria | 1 |
Singapore | 1 |
Spain | 1 |
South Africa | 1 |
Israel | 1 |
Italy | 1 |
Where are Research Centers of Sen-Jam Pharmaceutical Patents Located?
What Percentage of Sen-Jam Pharmaceutical US Patent Applications were Granted?
Sen-Jam Pharmaceutical (Excluding its subsidiaries) has filed 9 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 6 have been granted leading to a grant rate of 75%.
Below are the key stats of Sen-Jam Pharmaceutical patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Sen-Jam Pharmaceutical?
Law Firm | Total Applications | Success Rate |
Morgan Lewis & Bockius Llp Bo | 9 | 75.0% |
List of Sen-Jam Pharmaceutical patents
Sen-Jam Pharmaceutical Patents | Title |
US11464766B2 | Methods And Compositions To Inhibit Symptoms Associated With Veisalgia |
US11129803B2 | Methods And Compositions To Inhibit Tolerance To Opioids |
US10765630B2 | Methods And Compositions To Treat Enteropathic Arthritis |
US10675261B2 | Methods And Compositions To Inhibit Dependence On Opioids |
US10420756B2 | Methods And Compositions To Inhibit Symptoms Associated With Veisalgia |
US20230064685A1 | Methods And Compositions To Inhibit Symptoms Associated With Veisalgia |
US20220265585A1 | Methods And Compositions To Inhibit Symptoms Associated With Opioid Withdrawal |
US20220096409A1 | Methods And Compositions To Inhibit Tolerance To Opioids |
US20210212971A1 | Methods And Compositions To Inhibit Dependence On Opioids |
US20200297707A1 | Methods And Compositions To Inhibit Symptoms Associated With Viral Upper Respiratory Tract Infections |
EP3273952B1 | Combination Of Naproxen And Fexofenadine To Inhibit Symptoms Associated With Veisalgia |
EP4192457A1 | Compositions And Methods For Treating Or Preventing Disease Associated With Beta Coronavirus Infection |
EP3973957A1 | Methods And Compositions To Inhibit Symptoms Associated With Veisalgia |
AU2018333954B2 | Methods And Compositions To Inhibit Dependence On Opioids |
AU2021321535A1 | Compositions And Methods For Treating Or Preventing Disease Associated With Beta Coronavirus Infection |
AU2018333952A1 | Methods And Compositions To Inhibit Symptoms Associated With Opioid Withdrawal |
CA3076197A1 | Methods And Compositions To Inhibit Dependence On Opioids |
CA3076193A1 | Methods And Compositions To Inhibit Symptoms Associated With Opioid Withdrawal |
IL300406A | Compositions And Methods For Treating Or Preventing Disease Associated With Beta Coronavirus Infection |
SG11202300846SA | Compositions And Methods For Treating Or Preventing Disease Associated With Beta Coronavirus Infection |
BR112023002233A2 | Compositions And Methods For Treating Or Preventing Disease Associated With Beta Coronavirus Infection |
PL3273952T3 | Combination Of Naproxen And Fexofenadine To Inhibit Symptoms Associated With Veisalgia |
ES2926494T3 | Combination Of Naproxen And Fexofenadine To Inhibit Symptoms Associated With Veisalgia |
IT202200057570T2 | Combination Of Naproxene And Phexofenadine To Inhibit Symptoms Associated With Veisalgia |
MX2023001570A | Compositions And Methods For Treating Or Preventing A Disease Associated With Betacoronavirus Infection |
ZA202303234A | Compositions And Methods For Treating Or Preventing Disease Associated With Beta Coronavirus Infection |
AT1497959T | Kombination Von Naproxen Und Fexofenadine Zur Hemmung Von Symptomen Im Zusammenhang Mit Veisalgia |
NZ797537A | Compositions And Methods For Treating Or Preventing Disease Associated With Beta Coronavirus Infection |
US20200297673A1 | Methods And Compositions To Inhibit Dependence On Opioids |
US20190083430A1 | Methods And Compositions To Inhibit Symptoms Associated With Opioid Withdrawal |
US20180360811A1 | Methods And Compositions To Inhibit Symptoms Associated With Viral Upper Respiratory Tract Infections |
EP3684360A4 | Methods And Compositions To Inhibit Dependence On Opioids |
EP3684347A4 | Methods And Compositions To Inhibit Symptoms Associated With Opioid Withdrawal |
WO2022032069A1 | Compositions And Methods For Treating Or Preventing Disease Associated With Beta Coronavirus Infection |
WO2019178516A1 | Methods And Compositions To Treat Enteropathic Arthritis |
WO2019055942A4 | Methods And Compositions To Inhibit Tolerance To Opioids |
WO2019055941A1 | Methods And Compositions To Inhibit Dependence On Opioids |
WO2019055939A1 | Methods And Compositions To Inhibit Symptoms Associated With Opioid Withdrawal |
WO2019046201A1 | Methods And Compositions To Inhibit Adverse Effects Associated With Vaccinations |
WO2018232260A1 | Methods And Compositions To Inhibit Symptoms Associated With Viral Upper Respiratory Tract Infections |
What are Sen-Jam Pharmaceutical key innovation segments?
What Technologies are Covered by Sen-Jam Pharmaceutical?
The chart below distributes patents filed by Sen-Jam Pharmaceutical